Table 1.
Clinico-pathologic characteristics of rectal cancer patients
| Characteristics | Patients (N = 74) |
|---|---|
| Median age-years (range) | 72 (46–89) |
| > 60 years | 60 (81%) |
| < 60 years | 14 (19%) |
| Sex | |
| Male | 45 (61%) |
| Female | 29 (39%) |
| ECOG | |
| 0 | 41 (55%) |
| 1 | 31 (42%) |
| 2 | 2 (3%) |
| Status | |
| Death | 7 (10%) |
| Alive without disease | 59 (78%) |
| Alive with disease | 7 (10%) |
| N/A | 1 (1%) |
| T Downstaging | |
| 0 | 28 (38%) |
| 1 | 39 (53%) |
| N/A | 7 (9%) |
| N Downstaging | |
| 0 | 20 (27%) |
| 1 | 47 (64%) |
| N/A | 7 (9%) |
| Grade | |
| Low | 19 (26%) |
| High | 47 (63%) |
| N/A | 8 (11%) |
| Stage | |
| II | 4 (6%) |
| III | 69 (93%) |
| N/A | 1 (1%) |
| Neoadjuvant Treatment | |
| RT + Fluoropyrimidines based | 73 (99%) |
| Other | 1 (1%) |
| Treatment toxicity | |
| Yes | 30 (41%) |
| No | 44 (59%) |
| Pathological Response | |
| Complete | 9 (12%) |
| Partial | 27 (37%) |
| Minimun | 38 (51%) |
| DEK | |
| Low | 26 (35%) |
| High | 48 (65%) |
N/A not available, RT Radiotherapy